To celebrate the International Day of Women & Girls in Science 2025, Optimum asked women in healthcare to share their favourite scientific advancement or innovation. From cloning Dolly the sheep, to CRISPR gene editing and the miracle of IVF, we received a wide variety of wonderful answers. Read the campaign below to find out what […]
Cell and gene therapies have had a tough few years. Investors, their heads turned by weight loss drugs and put off from taking longer-term bets by higher interest rates, appear to have hardly noticed them. The sector is certainly facing challenges – not only sentiment, but practical hurdles too. But is the wind about […]
There’s a new acronym that is causing mayhem throughout Washington – the EO (executive order). President Donald Trump signed 46 of them in January, with 26 signed during his first day in office on 20th January. While many EOs are subject to challenges in the courts, they show Trump’s determination to stamp his authority from […]
For this year’s International Day of Women and Girls in Science, Optimum is celebrating the amazing women we work with by asking them to nominate their favourite scientific advancement or innovation. The answers are broad and varying and make for an uplifting read – learn what inspired the amazing women we work with to pursue […]
Alys Pharmaceuticals, Inc., an immuno-dermatology focused company, on Tuesday announced that the U.S. Food and Drug Administration (FDA) and Health Canada have cleared the Investigational New Drug (IND) / Clinical Trial Application (CTA) for the study of ALY-101 in patients suffering from Alopecia Areata (AA). Akribion Therapeutics exits from stealth with €8m seed financing to […]
